What Men Need to Know About Erection Meds - PDE5 Inhibitors

If you've ever looked into treatment for erectile dysfunction (ED), you've almost certainly come across the name Viagra. It's one of the most recognisable drug brands in the world — but it's really just the starting point of a broader class of medications called PDE5 inhibitors.

PDE5 inhibitors have been the first-line medical treatment for ED for over 25 years now, and the evidence behind them is strong. Yet many men still have questions: How do they actually work? Which one is best? Are they safe? This post breaks down the key facts so you can have a more informed conversation with your doctor.

Whether you're considering treatment for the first time or want to understand why your current medication was chosen, this guide covers the essentials — from mechanism of action to practical differences between the available options in Australia.

How PDE5 Inhibitors Actually Work

An erection depends on a chain of chemical events. When you're sexually aroused, nerves in the penis release nitric oxide, which triggers the production of a molecule called cyclic GMP (cGMP). This molecule relaxes the smooth muscle in penile blood vessels, allowing blood to flow in and produce an erection.

The enzyme phosphodiesterase type 5 (PDE5) breaks down cGMP, which is why erections naturally subside. PDE5 inhibitors block this enzyme, allowing cGMP to accumulate and sustain the erection for longer. Crucially, they don't create an erection out of nowhere — sexual stimulation is still required to initiate the nitric oxide release that starts the whole process.

This mechanism is why PDE5 inhibitors don't work as aphrodisiacs. They enhance a normal physiological response rather than creating desire. It also explains why they tend to be less effective in men with severe nerve damage (for example, after radical prostatectomy), where nitric oxide signalling is significantly impaired.

The Evidence: Do They Work?

In short, yes — and convincingly. A landmark 2009 meta-analysis by Tsertsvadze and colleagues, published in the Annals of Internal Medicine, pooled data from over 100 randomised controlled trials and found that all PDE5 inhibitors were significantly more effective than placebo at improving erectile function. Response rates across the class ranged from roughly 60% to 80%, depending on the specific drug, dose, and the underlying cause of ED.

The American Urological Association's 2018 guidelines reinforced this, giving PDE5 inhibitors a strong recommendation as first-line pharmacotherapy for ED. Similarly, the RACGP's guidelines for Australian general practitioners position these medications as the standard starting treatment after lifestyle factors and reversible causes have been addressed.

Importantly, the evidence also shows that efficacy can vary between individuals. A man who doesn't respond well to sildenafil may have a better result with tadalafil, and vice versa. This is why guidelines encourage trialling an adequate dose on multiple occasions before concluding a medication hasn't worked — typically at least six to eight attempts.

Sildenafil, Tadalafil, and the Others: What's the Difference?

There are four PDE5 inhibitors available in Australia: sildenafil (originally branded as Viagra), tadalafil (e.g. Cialis), vardenafil (e.g. Levitra), and avanafil (e.g. Spedra). They all work via the same mechanism, but differ in their pharmacokinetics — that is, how quickly they act and how long they last.

Sildenafil typically takes 30–60 minutes to kick in and lasts around four to six hours. It's the most widely studied and usually the most affordable. 

Tadalafil is the standout for duration — its effects can last up to 36 hours, earning it the nickname 'the weekend or honeymoon pill ; )' It can also be taken as a low daily dose (5 mg), which provides a continuous effect and removes the need to plan around a tablet. This daily dosing option is particularly popular among men who prefer spontaneity. It is also used for high blood pressure and in some cases, a large prostate - so keep in mind if you potentially can kill multiple birds with one stone. 

Vardenafil has a similar profile to sildenafil. Avanafil is the newest, with a slightly faster onset (as quick as 15 minutes) and potentially fewer side effects, though it's less commonly prescribed in Australia. Your doctor can help you decide which option best fits your lifestyle and health profile.

Side Effects and Safety Considerations

PDE5 inhibitors are generally well tolerated. The most common side effects — headache, facial flushing, nasal congestion, and indigestion — are related to their vasodilatory effects and are usually mild and temporary. Tadalafil can occasionally cause back pain or muscle aches due to its effect on PDE11, an enzyme found in skeletal muscle.

The most critical safety concern involves nitrate medications (such as glyceryl trinitrate for angina or amyl nitrate “poppers” used recreationally). Combining PDE5 inhibitors with nitrates can cause a dangerous, potentially fatal drop in blood pressure. This is an absolute contraindication (i.e. a NO-NO! Don't do it). 

If you use nitrates in any form — including sprays, patches, or tablets — you must tell your doctor before considering a PDE5 inhibitor.
 

Alpha-blockers used for prostate symptoms can also interact, though this can often be managed with dose adjustment and timing. The Princeton Consensus guidelines provide a useful framework for assessing cardiovascular risk: men who can perform moderate exercise (like brisk walking or climbing two flights of stairs) without symptoms are generally considered safe candidates for PDE5 inhibitor therapy.

Beyond Erections: Other Uses of PDE5 Inhibitors

It's worth knowing that PDE5 inhibitors aren't only used for ED. Tadalafil 5 mg daily is TGA-approved in Australia for treating the urinary symptoms of benign prostatic hyperplasia (BPH), making it a convenient option for men dealing with both conditions simultaneously. Sildenafil was originally developed as a cardiovascular drug, and it remains a mainstay treatment for pulmonary arterial hypertension under the brand name Revatio.

There's also emerging research into their potential benefits for endothelial function, exercise capacity, and even Raynaud's phenomenon, though these remain off-label uses. For the average man seeking help with ED, the key takeaway is that these are well-studied, versatile medications with a strong safety record when prescribed appropriately.

PDE5 inhibitors like sildenafil and tadalafil remain the gold standard for medical treatment of ED — backed by decades of high-quality evidence and recommended by every major urology and general practice guideline. They're effective, generally safe, and offer enough variety in their profiles that most men can find an option that suits them.

That said, ED is often a signal worth investigating further. It can be an early marker of cardiovascular disease, a consequence of hormonal changes, or linked to mental health. A script alone isn't a complete solution. If you're experiencing erectile difficulties, book an appointment to discuss the full picture — not just the medication, but the underlying cause and your broader health. That's where the real value lies.

Cheers, 

James.